Panbela Therapeutics Inc. (PBLA) last year’s performance of -99.85% is a clear signal for an entertaining trading season.

A new trading day began on Friday, with Panbela Therapeutics Inc. (NASDAQ: PBLA) stock price up 1.24% from the previous day of trading, before settling in for the closing price of $410.00. PBLA’s price has ranged from $1.06 to $930.00 over the past 52 weeks.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Meanwhile, its annual earnings per share averaged 99.50%.

Panbela Therapeutics Inc. (PBLA) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Panbela Therapeutics Inc. is 0.03%, while institutional ownership is 0.51%. The most recent insider transaction that took place on Nov 08, was worth 51,741. In this transaction 10% Owner of this company sold 72,874 shares at a rate of $0.71, taking the stock ownership to the 397,954 shares.

Panbela Therapeutics Inc. (PBLA) Recent Fiscal highlights

In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$53.8 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.48 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 99.50% per share during the next fiscal year.

Panbela Therapeutics Inc. (NASDAQ: PBLA) Trading Performance Indicators

Here are Panbela Therapeutics Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.21.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4016.17, a number that is poised to hit -24.34 in the next quarter and is forecasted to reach -81.60 in one year’s time.

Technical Analysis of Panbela Therapeutics Inc. (PBLA)

Compared to the last year’s volume of 1.07 million, its volume of 0.44 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 19.26%. Additionally, its Average True Range was 1.28.

During the past 100 days, Panbela Therapeutics Inc.’s (PBLA) raw stochastic average was set at 0.49%, which indicates a significant decrease from 4.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 452.52% in the past 14 days, which was higher than the 279.24% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $10.2082, while its 200-day Moving Average is $56.7395. Nevertheless, the first resistance level for the watch stands at $1.3000 in the near term. At $1.3600, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4600. If the price goes on to break the first support level at $1.1400, it is likely to go to the next support level at $1.0400. Now, if the price goes above the second support level, the third support stands at $0.9800.

Panbela Therapeutics Inc. (NASDAQ: PBLA) Key Stats

With a market capitalization of 6.03 million, the company has a total of 256K Shares Outstanding. Currently, annual sales are 0 K while annual income is -34,930 K. The company’s previous quarter sales were 0 K while its latest quarter income was -7,830 K.